期刊文献+

A53T α-synuclein抑制SH-SY5Y细胞2型囊泡单胺转运体的表达

A53T α-synuclein decreases the expression of type 2 vesicular monoamine transporter in neuroblastoma SH-SY5Y cells
下载PDF
导出
摘要 目的研究稳定表达A53Tα-synuclein对神经母细胞瘤SH-SY5Y细胞中2型囊泡单胺转运体(VMAT2)蛋白表达的影响。方法构建A53Tα-synuclein真核表达载体,用脂质体lipofectamineTM2000转染SHSY5Y细胞,经G418筛选获得稳定转染单克隆细胞株;分别采用Western blotting及DCFH-DA染色检测细胞系A53Tα-synuclein过表达对VMAT2蛋白的表达及细胞内活性氧类物质(ROS)水平的影响。结果 Western blotting结果显示VMAT2的表达在稳定表达A53Tα-synuclein的细胞系中明显降低。DCFH-DA染色结果显示稳定表达A53Tα-synuclein细胞系内DCF signal(507.3±7.1)较对照组(410.7±10.5)明显增多(P<0.05)。结论 A53Tα-synuclein能够通过抑制VMAT2的表达,增加细胞内的ROS水平,在帕金森病的发病过程中发挥重要作用。 Objective To investigate the effect of A53 T α-synuclein on the expression of type 2 vesicular monoamine transporter( VMAT2) in neuronblastoma SH-SY5 Y cells stably expressing A53 T α-synuclein. Methods A53 T α-synuclein eukaryotic plasmid was constructed by transfection of the SH-SY5 Y cells using LipofectamineTM2000,and a stable transfected monoclonal cell line was selected by G418. Western blotting and DCFH-DA staining were used to detect the effect of A53 T α-synuclein overexpression on the expression of VMAT2 protein and level of reactive oxygen species( ROS). Results Western blotting showed that compared with the control group,the expression of VMAT2 protein was significantly decreased,and DCFH-DA staining showed that DCF signal was significantly increased( 507. 3 ± 7. 1)than that in the cell line stably expressing A53 T α-synuclein( 410. 7 ± 10. 5)( P〈0. 05). Conclusions A53 T α-synuclein can increase the intracellular ROS level by inhibiting the expression of VMAT2,thereby playing an important role in the pathogenesis of Parkinson's disease.
出处 《中国比较医学杂志》 CAS 北大核心 2016年第8期66-69,共4页 Chinese Journal of Comparative Medicine
基金 山东省自然科学基金(ZR2011HM014) 山东省自然科学基金(ZR2015HL126)
关键词 帕金森氏病 A53Tα-synuclein VMAT2 Parkinson's disease A53T α-synuclein VMAT2
  • 相关文献

参考文献9

  • 1Spillantini MG, Schmidt ML, Lee Lewy bodies [J].Nature, 1997, VM, et al. Alpha-synuclein in 388 (6645) : 839 - 840.
  • 2Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson' s disease [J]. Science, 1997, 276(5321): 2045 -2047.
  • 3陈安琪,王建英,牟青杰,刘江月,崔晓栋,张代娟,郭军堂.A53Tα—synuclein与Ⅱ型单胺囊泡转移体相互作用的鉴定[J].中国临床实用医学,2008,2(7):43-45. 被引量:1
  • 4Lashuel HAl, Overk CR, Oueslati A, et al. The many faces of α - synuclein: from structure and toxicity to therapeutic target [J]. Nat RevNeurosci, 2013, 14(1): 38 -48.
  • 5Venda LLl, Cragg SJ, Buchman VL, et al. α-Synuclein and dopamine at the crossroads of Parkinson's disease [ J]. Trends Neurosci, 2010, 33(12) : 559 -568.
  • 6Peelaerts W, Bousset L, Van der Perren A, et al. α-Synuclein strains cause distinct synucleinopathies after local and systemic administration [J]. Nature, 2015, 522(7556): 340-344.
  • 7Jenner P, Olanow CW. Understanding cell death in Parkinson's disease [J]. Ann Neurol, 1998, 44(3 Suppl 1): S72-84.
  • 8Follmer C, Romao L, Einsiedler CM, et al. Dopamine affects the stability, hydration, and packing of protofibrils and fibrils of the wild type and variants of α-synuclein [ J ]. Biochemistry, 2007, 46(4) : 472 -482.
  • 9Parsons SM. Transport mechanisms in acetylcholine and monoamine storage [ J ]. FASEB J, 2000, 14 ( 15 ) : 2423 - 2434.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部